Patient and health care provider perceptions of cancer-related fatigue and pain

Supportive Care in Cancer

Volumn 24, Issue 10, 2016, Pages 4357-4363

  Williams, Loretta A ^a   Bohac, Chet ^b   Hunter, Sharon ^b   Cella, David ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b AMGEN INC   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Drug therapy; Fatigue; Neoplasms; Pain

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER FATIGUE; CANCER HORMONE THERAPY; CANCER PAIN; CANCER RADIOTHERAPY; DOCTOR PATIENT RELATION; FEMALE; GROUP PRACTICE; HEALTH PERSONNEL ATTITUDE; HEMATOLOGIST; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL ONCOLOGIST; METASTASIS; MOLECULARLY TARGETED THERAPY; NAUSEA AND VOMITING; NURSE PRACTITIONER; PATIENT ATTITUDE; PRIORITY JOURNAL; REGISTERED NURSE; SYMPTOM ASSESSMENT; UROGENITAL TRACT CANCER; COMPLICATION; FATIGUE; HEALTH CARE PERSONNEL; MIDDLE AGED; NEOPLASMS; PAIN; PERCEPTION; PSYCHOLOGY; QUESTIONNAIRE;

FATIGUE; FEMALE; HEALTH PERSONNEL; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PERCEPTION; SURVEYS AND QUESTIONNAIRES;

EID: 84969838806     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-016-3275-2     Document Type: Article

References (20)

1. Richardson A (1995) Fatigue in cancer patients: a review of the literature. Eur J Cancer Care 4(1):20–32
2. Cella D, Davis K, Breitbart W et al (2001) Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19(14):3385–3391
3. Cella D, Lai JS, Chang CH et al (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94(2):528–538
4. Demetri GD, Kris M, Wade J et al (1998) Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol 16(10):3412–3425
5. Curt GA, Breitbart W, Cella D et al (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the fatigue coalition. Oncologist 5(5):353–360
6. Littlewood TJ, Bajetta E, Nortier JW et al (2001) Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 19(11):2865–2874
7. Vogelzang NJ, Breitbart W, Cella D et al (1997) Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The fatigue coalition. Semin Hematol 34(3 Suppl 2):4–12
8. Basch E, Iasonos A, McDonough T et al (2006) Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol 7(11):903–909
9. Fromme EK, Eilers KM, Mori M et al (2004) How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J Clin Oncol 22(17):3485–3490
10. Fisch MJ, Lee JW, Weiss M et al (2012) Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol 30(16):1980–1988
11. Gilbert A, Sebag-Montefiore D, Davidson S et al (2015) Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic. Gynecol Oncol 136(3):429–439
12. Basch E (2014) The rationale for collecting patient-reported symptoms during routine chemotherapy. Am Soc Clin Oncol Educ Book 2014:161–165
13. Bennett AV, Jensen RE, Basch E (2012) Electronic patient-reported outcome systems in oncology clinical practice. CA Cancer J Clin 62(5):337–347
14. Wu AW, Kharrazi H, Boulware LE et al (2013) Measure once, cut twice—adding patient-reported outcome measures to the electronic health record for comparative effectiveness research. J Clin Epidemiol 66(8 Suppl):S12–S20
15. Hughes EF, Wu AW, Carducci MA et al (2012) What can I do? Recommendations for responding to issues identified by patient-reported outcomes assessments used in clinical practice. J Support Oncol 10(4):143–148
16. Guidance for industry: patient reported outcome measures: use in medical product development to support labelling claims. Silver Spring, MD: Food and Drug Administration, 2009. Available from: http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf. Accessed 13 Jan 2016.
17. Reflection paper on the use of patient reported outcomes (PRO) measures in oncology studies. London, United Kingdom: European Medicines Agency, 2014. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/06/WC500168852.pdf. Accessed 13 Jan 2016.
18. Cramp F, Daniel J (2008) Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 2:CD006145
19. Couper M (2000) Web surveys: a review of issues and approaches. Public Opin Q 64(4):464–494
20. Paoli CJ, Bach BA, Quach D et al (2014) Performance status of real-world oncology patients before and after first course of chemotherapy. J Community Support Oncol 12:163–170